EAPH
$0.01
-0.00 (-5.47%)
Easton
EAPH
$0.01
-0.00 (-5.47%)
Easton Pharmaceuticals, Inc. | OTCPK - Current
Post-Market:$0.010.00 (0.00%)
Get Alerts
(3,873 followers)
1d5d1m6m1y5y10y Advanced Chart
52wk high:0.06
52wk low:0.01
EPS:-0.00
PE (ttm):-
Div Rate (ttm):-
Yield (ttm):-
Market Cap:$17.72M
Volume:3,457,504
Latest
|Analysis
|News
|Stocktalk
|Key Data
|Financials
All
|M&A
|Press Releases
Former Blackrock exec to raise $250M to invest in pot businesses
Bloomberg reports that former Blackrock executive Chris Leavy is co-chairing a $250M private equity fund, MedMen Opportunity Fund II, aimed at investing in marijuana businesses.
The fund, specifically targeting companies that cultivate, manufacture and sell pot, is setting up shop in the U.S.'s most popular tourist destinations.
New York recently added chronic pain as a qualifying condition for medical marijuana. California's recreational market opens next year. Nevada approved it for adults in July and Canada plans to legalize it by next summer. Eight U.S. states have legalized recreational use and another 21 allow it for medicinal purposes.
According to Cowen & Co., the $6B legal cannabis market is expected to grow (no pun intended) to $50B by 2026.
Selected tickers: (SMG -0.7%)(OTCPK:CBIS -4.1%)(OTCPK:GRNH +1.4%)(OTCPK:EAPH +1.4%)
Easton Pharmaceuticals Inc (EAPH) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...
Continue Reading
A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...
Continue Reading
Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...
Continue Reading
Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....
Continue Reading
History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...
Continue Reading
AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...
Continue Reading
You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...
Continue Reading
Top 5 Most Recently Viewed Articles
Modine Expands Manufacturing Capacity in Calgary Modine (NYSE: MOD), a prominent player in thermal management technology, has proudly opened a new state-of-the-art facility spanning 23,200m² (~250,000ft²) to enhance support for the rapidly increasing demand from data centers, especially within the hyperscale market. This facility is dedicated to the production of...
Continue Reading
Choice Hotels Champions Wildfire Relief with Donation Match Program In a heartfelt initiative, Choice Hotels International, Inc. (NYSE: CHH) has launched a campaign aimed at providing critical support to those affected by recent California wildfires. This effort focuses on empowering Choice Privileges members to contribute to the relief while amplifying their donations...
Continue Reading
APR Corp. Unveils Ambitious Plans for CES 2025 APR Corp. is set to make significant waves in the global beauty market by returning to CES for a second year, aiming to expand its presence internationally. Building on its successful launch at CES 2024, the beauty tech innovator is gearing up for CES 2025 with exciting new developments. Showcasing Innovative Beauty...
Continue Reading
Behind Asia's Facade of Stability Smile and wave, folks, because Asia's B2B credit scene ain't as rosy as the headlines might want you to believe. Sure, on the surface, things look stable, but dig a little deeper and there’s a whole heap of troubles brewing, especially for the smaller fry. It’s like watching a family portrait while the kids are bickering behind the...
Continue Reading
CYIOS Corporation Engages Atlanta Capital Partners for IR Strategy CYIOS Corporation LLC (OTC: CYIO) is making strides in its investor relations approach by hiring Atlanta Capital Partners, LLC. This strategic move aims to enhance CYIOS's visibility in the financial market and streamline communications within the investment community. Introducing Atlanta Capital Partners...
Continue Reading